Novan Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Novan in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Novan stock.
View analyst ratings for Novan or view top-rated stocks.

Wall Street analysts have given Novan a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Novan wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Novan saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 4,070,000 shares, a decrease of 23.5% from the February 28th total of 5,320,000 shares. Based on an average daily volume of 20,640,000 shares, the days-to-cover ratio is presently 0.2 days.
View Novan's Short Interest.

Novan is scheduled to release its next quarterly earnings announcement on Wednesday, May 19th 2021.
View our earnings forecast for Novan.

Novan, Inc. (NASDAQ:NOVN) issued its quarterly earnings results on Friday, October, 30th. The company reported ($0.06) earnings per share for the quarter, meeting the consensus estimate of ($0.06). The company had revenue of $1.32 million for the quarter, compared to analyst estimates of $1.24 million.
View Novan's earnings history.

Novan's stock was trading at $0.52 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, NOVN shares have increased by 158.7% and is now trading at $1.3450.
View which stocks have been most impacted by COVID-19.

1 Wall Street analysts have issued 12 month price objectives for Novan's shares. Their forecasts range from $1.50 to $1.50. On average, they anticipate Novan's stock price to reach $1.50 in the next twelve months. This suggests a possible upside of 11.5% from the stock's current price.
View analysts' price targets for Novan or view top-rated stocks among Wall Street analysts.

Some companies that are related to Novan include Epizyme (EPZM), ADVANZ PHARMA (CXRXF), Amphastar Pharmaceuticals (AMPH), Collegium Pharmaceutical (COLL), Karyopharm Therapeutics (KPTI), Lexicon Pharmaceuticals (LXRX), Intercept Pharmaceuticals (ICPT), Esperion Therapeutics (ESPR), ORIC Pharmaceuticals (ORIC), BELLUS Health (BLUSF), Veru (VERU), ZIOPHARM Oncology (ZIOP), Chimerix (CMRX), VBI Vaccines (VBIV) and Ardelyx (ARDX).
View all of NOVN's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Novan investors own include Bionano Genomics (BNGO), Gran Tierra Energy (GTE), Pennsylvania Real Estate Investment Trust (PEI), ADMA Biologics (ADMA), Cannabics Pharmaceuticals (CNBX), Matinas BioPharma (MTNB), Zosano Pharma (ZSAN), Aeterna Zentaris (AEZS), CBL & Associates Properties (CBL) and OrganiGram (OGI).

(NOVN) raised $46 million in an initial public offering on Wednesday, September 21st 2016. The company issued 3,800,000 shares at $11.00-$13.00 per share. Piper Jaffray served as the underwriter for the IPO and JMP Securities and Wedbush PacGrow were co-managers.

Novan trades on the NASDAQ under the ticker symbol "NOVN."

Shares of NOVN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NOVN stock can currently be purchased for approximately $1.35.

Novan has a market capitalization of $203.97 million and generates $4.90 million in revenue each year. The company earns $-30,640,000.00 in net income (profit) each year or ($0.80) on an earnings per share basis.

Novan employs 24 workers across the globe.

The official website for Novan is www.novan.com.

Novan is headquartered at 4105 HOPSON ROAD, MORRISVILLE NC, 27560.

Novan's mailing address is 4105 HOPSON ROAD, MORRISVILLE NC, 27560. The company can be reached via phone at (919) 485-8080 or via email at [email protected]